Cwm, LLC Spectrum Pharmaceuticals Inc Transaction History

Cwm, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	SELL	$0.43 - $1.56 $21 - $78	-50 Reduced 80.65%	12 $0
Q2 2022 Jul 28, 2022	BUY	$0.7 - $1.4 $35 - $70	50 Added 416.67%	62 $0
Q1 2022 Apr 21, 2022	SELL	$0.63 - $1.59 $2,705 - $6,829	-4,295 Reduced 99.72%	12 $0
Q4 2021 Jan 31, 2022	BUY	$1.27 - $2.42 $5,454 - $10,393	4,295 Added 35791.67%	4,307 $5,000
Q2 2020 Sep 15, 2021	BUY	$2.11 - $3.38 $25 - $40	12 New	12 $0
Q2 2020 Jul 22, 2020	SELL	$2.11 - $3.38 $25 - $40	-12 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	$1.83 - $3.45 $21 - $41	12 New	12 $0
Q1 2020 Apr 28, 2020	SELL	$1.83 - $3.45 $21 - $41	-12 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$3.5 - $10.35 $42 - $124	12 New	12 $0
Q4 2019 Jan 27, 2020	SELL	$3.5 - $10.35 $42 - $124	-12 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$7.03 - $9.7 $84 - $116	12 New	12 $0
Q3 2019 Oct 22, 2019	SELL	$7.03 - $9.7 $84 - $116	-12 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$7.36 - $11.26 $88 - $135	12 New	12 $0
Q2 2019 Jul 31, 2019	SELL	$7.36 - $11.26 $88 - $135	-12 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$9.08 - $11.84 $72 - $94	8 Added 200.0%	12 $0
Q1 2019 Apr 22, 2019	BUY	$9.08 - $11.84 $36 - $47	4 New	4 $0

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.